Wstęp
Ta strona zawiera kompleksową analizę znanej historii wykorzystywania informacji poufnych w firmie Lindsey Rolfe. Insiderzy to członkowie kadry kierowniczej, dyrektorzy lub znaczący inwestorzy w spółce. Dokonywanie transakcji w ich firmach w oparciu o określone, niepubliczne informacje jest nielegalne. Nie oznacza to, że dokonywanie jakichkolwiek transakcji we własnych firmach jest nielegalne. Muszą jednak zgłaszać wszystkie transakcje do SEC za pośrednictwem formularza 4. Pomimo tych ograniczeń badania akademickie sugerują, że insiderzy – ogólnie rzecz biorąc – mają tendencję do osiągania lepszych wyników na rynku w swoich własnych firmach.
Średnia rentowność handlu
Średnia rentowność handlu to średni zwrot ze wszystkich zakupów na otwartym rynku dokonanych przez osobę mającą dostęp do informacji poufnych w ciągu ostatnich trzech lat. Aby to obliczyć, badamy każdy nieplanowany zakup na otwartym rynku dokonany przez insidera, z wyłączeniem wszystkich transakcji oznaczonych jako część planu handlowego 10b5-1. Następnie obliczamy średnią wydajność tych transakcji w ciągu 3, 6 i 12 miesięcy, uśredniając każdy z tych okresów, aby wygenerować ostateczny wskaźnik wydajności dla każdej transakcji. Na koniec uśredniamy wszystkie wskaźniki wydajności, aby obliczyć wskaźnik wydajności dla insidera. Na tej liście znajdują się wyłącznie insiderzy, którzy dokonali co najmniej trzech transakcji w ciągu ostatnich dwóch lat.
Jeśli rentowność handlu insiderów jest oznaczona notką„nie dotyczy”, oznacza to, że insider albo nie dokonał żadnych zakupów na otwartym rynku w ciągu ostatnich trzech lat, albo transakcje, których dokonał, są zbyt nowe, aby obliczyć wiarygodny wskaźnik wydajności.
Częstotliwość aktualizacji: codziennie
Spółki posiadające zgłoszone stanowiska osób mających dostęp do poufnych informacji
Z dokumentów SEC wynika, że Lindsey Rolfe zgłosił udziały lub transakcje w następujących spółkach:
| Papier wartościowy | Nazwa | Najnowsze raporty dotyczące udziałów |
|---|---|---|
| US:CLVS / Clovis Oncology Inc | See Remarks | 113 691 |
| US:BCEL / Atreca, Inc. | Director | 12 000 |
Jak interpretować wykresy
Poniższe wykresy przedstawiają notowania akcji papierów wartościowych po każdej niezaplanowanej transakcji na otwartym rynku dokonanej przez Lindsey Rolfe. Nieplanowane transakcje to transakcje, które nie zostały dokonane w ramach planu handlowego 10b5-1. Notowania akcji przedstawiono na wykresie jako skumulowaną procentową zmianę ceny akcji. Na przykład, jeśli 1 stycznia 2019 r. dokonano transakcji poufnej, wykres pokaże dzienną procentową zmianę papieru wartościowego do dnia dzisiejszego. Jeżeli cena akcji wzrosłaby w tym czasie z 10 do 15 dolarów, skumulowana procentowa zmiana ceny akcji wyniosłaby 50%. Zmiana ceny z 10$ na 20$ będzie wynosić 100%, a zmiana ceny z 10$ na 5$ będzie wynosić -50%.
Ostatecznie staramy się określić, jak blisko transakcje insiderów korelują z nadmiernymi zwrotami (dodatnimi lub ujemnymi) z ceny akcji, aby sprawdzić, czy insider dostosowuje swoje transakcje w taki sposób, aby czerpać korzyści z informacji poufnych. Rozważmy sytuację, w której zrobił to ktoś z wewnątrz. W tej sytuacji oczekiwalibyśmy albo (a) dodatnich zwrotów po zakupach, albo (b) ujemnych zwrotów po sprzedaży. W przypadku (a) wykres ZAKUPU pokazywałby serię krzywych nachylonych w górę, wskazujących dodatnie zwroty po każdej transakcji zakupu. W przypadku (b) wykres SPRZEDAŻ pokazywałby serię krzywych o nachyleniu w dół, wskazujących ujemne zwroty po każdej transakcji sprzedaży.
Samo to jednak nie wystarczy, aby wyciągnąć wnioski. Gdyby np. cena akcji spółki przez wiele lat rosła niecyklicznie, to spodziewalibyśmy się, że wszystkie wykresy po zakupie będą wykazywały tendencję wzrostową. Podobnie niecykliczne spadki na przestrzeni wielu lat spowodowałyby spadek linii na wykresie po transakcjach. Żaden z tych wykresów nie sugeruje wykorzystywania informacji poufnych.
Najsilniejszym wskaźnikiem byłaby sytuacja, gdy cena akcji miała charakter wyjątkowo cykliczny, a na wykresie KUPNO występowały zarówno pozytywne sygnały na wykresie KUPNA, jak i negatywne na wykresie SPRZEDAŻY. Sytuacja ta wysoce sugerowałaby osobę mającą dostęp do informacji poufnych, która wykorzystywała transakcje w celu uzyskania korzyści finansowej.
Historia handlu insiderów
Ta tabela przedstawia pełną listę transakcji insiderów dokonanych przez firmę Lindsey Rolfe ujawnioną Komisji Papierów Wartościowych (SEC).
| Data pliku | Data trans | Formularz | Ticker | Bezpieczeństwo | Kod | Akcje | Pozostałe akcje | Zmiana procent |
Cena udziału |
Wartość trans |
Pozostała Wartość |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -2 353 | 113 691 | -2,03 | 0,98 | -2 313 | 111 747 | |
| 2022-11-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -1 908 | 111 419 | -1,68 | 0,98 | -1 875 | 109 514 | |
| 2022-11-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 4 625 | 116 044 | 4,15 | ||||
| 2022-11-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 3 749 | 113 327 | 3,42 | ||||
| 2022-09-06 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -2 545 | 109 578 | -2,27 | 1,20 | -3 054 | 131 494 | |
| 2022-09-06 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 5 063 | 112 123 | 4,73 | ||||
| 2022-08-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -2 391 | 107 060 | -2,18 | 1,46 | -3 493 | 156 404 | |
| 2022-08-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -1 939 | 104 826 | -1,82 | 1,46 | -2 833 | 153 140 | |
| 2022-08-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 4 625 | 109 451 | 4,41 | ||||
| 2022-08-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 3 749 | 106 765 | 3,64 | ||||
| 2022-06-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -2 650 | 103 016 | -2,51 | 0,64 | -1 703 | 66 188 | |
| 2022-06-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 5 062 | 105 666 | 5,03 | ||||
| 2022-05-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -2 348 | 100 604 | -2,28 | 1,97 | -4 625 | 198 170 | |
| 2022-05-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -1 904 | 98 327 | -1,90 | 1,97 | -3 750 | 193 685 | |
| 2022-05-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -4 625 | 32 375 | -12,50 | ||||
| 2022-05-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -3 749 | 11 248 | -25,00 | ||||
| 2022-05-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 4 625 | 102 952 | 4,70 | ||||
| 2022-05-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 3 749 | 100 231 | 3,89 | ||||
| 2022-03-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -10 585 | 96 482 | -9,89 | 1,87 | -19 752 | 180 035 | |
| 2022-03-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -360 | 86 817 | -0,41 | 1,87 | -672 | 162 001 | |
| 2022-03-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | 688 | 0 | -100,00 | ||||
| 2022-03-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | 20 250 | 60 750 | 50,00 | ||||
| 2022-03-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
A - Award | 81 000 | 81 000 | |||||
| 2022-03-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 20 250 | 107 067 | 23,32 | ||||
| 2022-03-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 688 | 87 177 | 0,80 | ||||
| 2022-02-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -2 493 | 86 489 | -2,80 | 1,94 | -4 836 | 167 763 | |
| 2022-02-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -2 021 | 84 357 | -2,34 | 1,94 | -3 920 | 163 619 | |
| 2022-02-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -4 625 | 37 000 | -11,11 | ||||
| 2022-02-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -3 750 | 14 997 | -20,00 | ||||
| 2022-02-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 4 625 | 88 982 | 5,48 | ||||
| 2022-02-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 3 750 | 86 378 | 4,54 | ||||
| 2021-12-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -346 | 82 628 | -0,42 | 3,00 | -1 038 | 247 884 | |
| 2021-12-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -687 | 688 | -49,96 | ||||
| 2021-12-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 687 | 82 974 | 0,83 | ||||
| 2021-11-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -2 325 | 82 287 | -2,75 | 4,55 | -10 579 | 374 406 | |
| 2021-11-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -1 884 | 79 987 | -2,30 | 4,55 | -8 572 | 363 941 | |
| 2021-11-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -4 625 | 41 625 | -10,00 | ||||
| 2021-11-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -3 749 | 18 747 | -16,67 | ||||
| 2021-11-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 4 625 | 84 612 | 5,78 | ||||
| 2021-11-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 3 749 | 81 871 | 4,80 | ||||
| 2021-09-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -347 | 78 122 | -0,44 | 4,89 | -1 697 | 382 017 | |
| 2021-09-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -688 | 1 375 | -33,35 | ||||
| 2021-09-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 688 | 78 469 | 0,88 | ||||
| 2021-08-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -2 317 | 77 781 | -2,89 | 4,82 | -11 168 | 374 904 | |
| 2021-08-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -1 878 | 75 473 | -2,43 | 4,82 | -9 052 | 363 780 | |
| 2021-08-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -4 625 | 46 250 | -9,09 | ||||
| 2021-08-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -3 749 | 22 496 | -14,28 | ||||
| 2021-08-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 4 625 | 80 098 | 6,13 | ||||
| 2021-08-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 3 749 | 77 351 | 5,09 | ||||
| 2021-06-11 |
|
4 | BCEL |
Atreca, Inc.
Stock Option (right to buy) |
A - Award | 12 000 | 12 000 | |||||
| 2021-06-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -322 | 73 602 | -0,44 | 5,63 | -1 813 | 414 379 | |
| 2021-06-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | 687 | 2 063 | 49,93 | ||||
| 2021-06-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 687 | 73 924 | 0,94 | ||||
| 2021-05-04 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -2 486 | 73 237 | -3,28 | 5,54 | -13 772 | 405 733 | |
| 2021-05-04 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -2 015 | 71 098 | -2,76 | 5,54 | -11 163 | 393 883 | |
| 2021-05-04 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -4 625 | 50 875 | -8,33 | ||||
| 2021-05-04 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -3 749 | 26 245 | -12,50 | ||||
| 2021-05-04 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 4 625 | 75 723 | 6,51 | ||||
| 2021-05-04 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 3 749 | 73 113 | 5,40 | ||||
| 2021-03-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -346 | 69 364 | -0,50 | 6,29 | -2 176 | 436 300 | |
| 2021-03-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -315 | 69 022 | -0,45 | 6,29 | -1 981 | 434 148 | |
| 2021-03-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | 688 | 2 750 | 33,37 | ||||
| 2021-03-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | 625 | 0 | -100,00 | ||||
| 2021-03-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
A - Award | 81 000 | 81 000 | |||||
| 2021-03-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 688 | 69 710 | 1,00 | ||||
| 2021-03-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 625 | 69 337 | 0,91 | ||||
| 2021-02-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -9 822 | 68 712 | -12,51 | 7,97 | -78 281 | 547 635 | |
| 2021-02-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -1 991 | 60 034 | -3,21 | 7,97 | -15 868 | 478 471 | |
| 2021-02-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -18 500 | 55 500 | -25,00 | ||||
| 2021-02-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -3 750 | 29 994 | -11,11 | ||||
| 2021-02-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 18 500 | 78 534 | 30,82 | ||||
| 2021-02-03 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 3 750 | 62 025 | 6,44 | ||||
| 2020-12-23 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -3 438 | 0 | -100,00 | ||||
| 2020-12-23 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -1 728 | 58 275 | -2,88 | 5,68 | -9 815 | 331 002 | |
| 2020-12-23 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 3 438 | 60 003 | 6,08 | ||||
| 2020-12-16 |
|
4 | CLVS |
Clovis Oncology, Inc.
Employee Stock Option (right to buy) |
M - Exercise | -17 241 | 0 | -100,00 | ||||
| 2020-12-16 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
F - Taxes | -14 153 | 56 565 | -20,01 | 5,11 | -72 322 | 289 047 | |
| 2020-12-16 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 17 241 | 70 718 | 32,24 | 3,28 | 56 550 | 231 955 | |
| 2020-12-07 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -687 | 3 438 | -16,65 | ||||
| 2020-12-07 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -625 | 625 | -50,00 | ||||
| 2020-12-07 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -346 | 53 477 | -0,64 | 4,89 | -1 692 | 261 503 | |
| 2020-12-07 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 687 | 53 823 | 1,29 | ||||
| 2020-12-07 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -315 | 53 136 | -0,59 | 4,89 | -1 540 | 259 835 | |
| 2020-12-07 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 625 | 53 451 | 1,18 | ||||
| 2020-11-05 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -3 749 | 33 744 | -10,00 | ||||
| 2020-11-05 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -1 920 | 52 826 | -3,51 | 4,93 | -9 466 | 260 432 | |
| 2020-11-05 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 3 749 | 54 746 | 7,35 | ||||
| 2020-09-23 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -3 437 | 3 438 | -49,99 | ||||
| 2020-09-23 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -1 726 | 50 997 | -3,27 | 6,85 | -11 823 | 349 329 | |
| 2020-09-23 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -21 | 52 723 | -0,04 | 6,86 | -144 | 361 680 | |
| 2020-09-23 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 3 437 | 52 744 | 6,97 | ||||
| 2020-09-08 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -688 | 4 125 | -14,29 | ||||
| 2020-09-08 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -625 | 1 250 | -33,33 | ||||
| 2020-09-08 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -329 | 49 307 | -0,66 | 5,30 | -1 744 | 261 327 | |
| 2020-09-08 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 688 | 49 636 | 1,41 | ||||
| 2020-09-08 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -299 | 48 948 | -0,61 | 5,30 | -1 585 | 259 424 | |
| 2020-09-08 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 625 | 49 247 | 1,29 | ||||
| 2020-08-05 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -3 749 | 37 493 | -9,09 | ||||
| 2020-08-05 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -1 899 | 48 622 | -3,76 | 5,92 | -11 242 | 287 842 | |
| 2020-08-05 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 3 749 | 50 521 | 8,02 | ||||
| 2020-06-23 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -3 438 | 6 875 | -33,34 | ||||
| 2020-06-23 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -1 728 | 46 772 | -3,56 | 6,74 | -11 647 | 315 243 | |
| 2020-06-23 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 3 438 | 48 500 | 7,63 | ||||
| 2020-06-15 |
|
4 | BCEL |
Atreca, Inc.
Stock Option (right to buy) |
A - Award | 12 000 | 12 000 | |||||
| 2020-06-05 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -687 | 4 813 | -12,49 | ||||
| 2020-06-05 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -625 | 1 875 | -25,00 | ||||
| 2020-06-05 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -356 | 45 062 | -0,78 | 7,03 | -2 503 | 316 786 | |
| 2020-06-05 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 687 | 45 418 | 1,54 | ||||
| 2020-06-05 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -324 | 44 731 | -0,72 | 7,03 | -2 278 | 314 459 | |
| 2020-06-05 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 625 | 45 055 | 1,41 | ||||
| 2020-05-07 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -3 749 | 41 242 | -8,33 | ||||
| 2020-05-07 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -1 677 | 44 430 | -3,64 | 8,10 | -13 584 | 359 883 | |
| 2020-05-07 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 3 749 | 46 107 | 8,85 | ||||
| 2020-04-08 |
|
4 | CLVS |
Clovis Oncology, Inc.
Employee Stock Option (right to buy) |
M - Exercise | -23 034 | 0 | -100,00 | ||||
| 2020-04-08 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
F - Taxes | -16 733 | 42 358 | -28,32 | 6,80 | -113 784 | 288 034 | |
| 2020-04-08 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 23 034 | 59 091 | 63,88 | 3,08 | 70 945 | 182 000 | |
| 2020-03-23 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -3 437 | 10 313 | -25,00 | ||||
| 2020-03-23 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -1 728 | 36 057 | -4,57 | 4,60 | -7 949 | 165 862 | |
| 2020-03-23 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 3 437 | 37 785 | 10,01 | ||||
| 2020-03-05 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -688 | 5 500 | -11,12 | ||||
| 2020-03-05 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -625 | 2 500 | -20,00 | ||||
| 2020-03-05 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -360 | 34 348 | -1,04 | 7,20 | -2 592 | 247 306 | |
| 2020-03-05 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 688 | 34 708 | 2,02 | ||||
| 2020-03-05 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -327 | 34 020 | -0,95 | 7,20 | -2 354 | 244 944 | |
| 2020-03-05 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 625 | 34 347 | 1,85 | ||||
| 2020-02-06 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -14 997 | 44 991 | -25,00 | ||||
| 2020-02-06 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -7 503 | 33 722 | -18,20 | 8,41 | -63 100 | 283 602 | |
| 2020-02-06 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 14 997 | 41 225 | 57,18 | ||||
| 2020-01-31 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
A - Award | 74 000 | 74 000 | |||||
| 2019-12-26 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -3 438 | 13 750 | -20,00 | ||||
| 2019-12-26 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -1 729 | 26 228 | -6,18 | 11,30 | -19 538 | 296 376 | |
| 2019-12-26 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 3 438 | 27 957 | 14,02 | ||||
| 2019-12-05 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -687 | 6 188 | -9,99 | ||||
| 2019-12-05 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -625 | 3 125 | -16,67 | ||||
| 2019-12-05 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -353 | 24 519 | -1,42 | 14,61 | -5 157 | 358 223 | |
| 2019-12-05 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 687 | 24 872 | 2,84 | ||||
| 2019-12-05 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -321 | 24 185 | -1,31 | 14,59 | -4 683 | 352 859 | |
| 2019-12-05 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 625 | 24 506 | 2,62 | ||||
| 2019-09-24 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -3 437 | 17 188 | -16,66 | ||||
| 2019-09-24 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -1 744 | 23 881 | -6,81 | 4,80 | -8 371 | 114 629 | |
| 2019-09-24 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 3 437 | 25 625 | 15,49 | ||||
| 2019-09-06 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -688 | 6 875 | -9,10 | ||||
| 2019-09-06 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -625 | 3 750 | -14,29 | ||||
| 2019-09-06 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -375 | 22 188 | -1,66 | 5,21 | -1 954 | 115 599 | |
| 2019-09-06 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 688 | 22 563 | 3,15 | ||||
| 2019-09-06 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -341 | 21 875 | -1,53 | 5,21 | -1 777 | 113 969 | |
| 2019-09-06 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 625 | 22 216 | 2,89 | ||||
| 2019-08-22 |
|
4 | BCEL |
Atreca, Inc.
Stock Option (right to buy) |
A - Award | 24 000 | 24 000 | |||||
| 2019-06-24 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -3 438 | 20 625 | -14,29 | ||||
| 2019-06-24 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -1 728 | 21 591 | -7,41 | 14,70 | -25 402 | 317 388 | |
| 2019-06-24 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 3 438 | 23 319 | 17,29 | ||||
| 2019-06-06 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -687 | 7 563 | -8,33 | ||||
| 2019-06-06 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -625 | 4 375 | -12,50 | ||||
| 2019-06-06 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -343 | 19 881 | -1,70 | 15,07 | -5 169 | 299 607 | |
| 2019-06-06 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 687 | 20 224 | 3,52 | ||||
| 2019-06-06 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -312 | 19 537 | -1,57 | 15,07 | -4 702 | 294 423 | |
| 2019-06-06 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 625 | 19 849 | 3,25 | ||||
| 2019-03-21 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -3 437 | 24 063 | -12,50 | ||||
| 2019-03-21 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -1 729 | 19 224 | -8,25 | 26,13 | -45 179 | 502 323 | |
| 2019-03-21 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 3 437 | 20 953 | 19,62 | ||||
| 2019-03-06 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -2 750 | 8 250 | -25,00 | ||||
| 2019-03-06 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -625 | 5 000 | -11,11 | ||||
| 2019-03-06 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -1 410 | 17 516 | -7,45 | 29,29 | -41 299 | 513 044 | |
| 2019-03-06 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 2 750 | 18 926 | 17,00 | ||||
| 2019-03-06 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -321 | 16 176 | -1,95 | 29,29 | -9 402 | 473 795 | |
| 2019-03-06 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 625 | 16 497 | 3,94 | ||||
| 2019-02-04 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
A - Award | 59 988 | 59 988 | |||||
| 2019-02-04 |
|
4 | CLVS |
Clovis Oncology, Inc.
Stock Option (right to buy) |
A - Award | 19 996 | 19 996 | |||||
| 2018-12-26 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -3 438 | 27 500 | -11,11 | ||||
| 2018-12-26 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -1 728 | 15 872 | -9,82 | 17,72 | -30 620 | 281 252 | |
| 2018-12-26 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 3 438 | 17 600 | 24,28 | ||||
| 2018-12-06 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -625 | 5 625 | -10,00 | ||||
| 2018-12-06 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -284 | 14 162 | -1,97 | 21,23 | -6 029 | 300 659 | |
| 2018-12-06 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 625 | 14 446 | 4,52 | ||||
| 2018-09-24 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -3 437 | 30 938 | -10,00 | ||||
| 2018-09-24 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
F - Taxes | -1 728 | 13 821 | -11,11 | 32,21 | -55 659 | 445 174 | |
| 2018-09-24 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 3 437 | 15 549 | 28,38 | ||||
| 2018-09-07 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -625 | 6 250 | -9,09 | ||||
| 2018-09-07 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
F - Taxes | -321 | 12 112 | -2,58 | 35,75 | -11 476 | 433 004 | |
| 2018-09-07 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 625 | 12 433 | 5,29 | ||||
| 2018-06-21 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -3 438 | 34 375 | -9,09 | ||||
| 2018-06-21 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
F - Taxes | -1 728 | 11 808 | -12,77 | 45,75 | -79 056 | 540 216 | |
| 2018-06-21 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 3 438 | 13 536 | 34,05 | ||||
| 2018-06-08 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -625 | 6 875 | -8,33 | ||||
| 2018-06-08 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
F - Taxes | -316 | 10 098 | -3,03 | 47,70 | -15 073 | 481 675 | |
| 2018-06-08 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 625 | 10 414 | 6,38 | ||||
| 2018-03-21 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -3 437 | 37 813 | -8,33 | ||||
| 2018-03-21 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
F - Taxes | -1 728 | 9 789 | -15,00 | 56,75 | -98 064 | 555 526 | |
| 2018-03-21 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 3 437 | 11 517 | 42,54 | ||||
| 2018-03-09 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -2 500 | 7 500 | -25,00 | ||||
| 2018-03-09 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
F - Taxes | -1 260 | 8 080 | -13,49 | 58,43 | -73 622 | 472 114 | |
| 2018-03-09 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 2 500 | 9 340 | 36,55 | ||||
| 2018-03-02 |
|
4 | CLVS |
Clovis Oncology, Inc.
Stock Option (right to buy) |
A - Award | 11 000 | 11 000 | |||||
| 2018-03-02 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
A - Award | 11 000 | 11 000 | |||||
| 2017-12-21 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
M - Exercise | -13 750 | 41 250 | -25,00 | ||||
| 2017-12-21 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
F - Taxes | -6 910 | 6 840 | -50,25 | 63,80 | -440 858 | 436 392 | |
| 2017-12-21 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 13 750 | 13 750 | |||||
| 2017-03-28 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
A - Award | 10 000 | 10 000 | |||||
| 2017-03-28 |
|
4 | CLVS |
Clovis Oncology, Inc.
Stock Option (right to buy) |
A - Award | 20 000 | 20 000 | |||||
| 2016-12-19 |
|
4 | CLVS |
Clovis Oncology, Inc.
Restricted Stock Units |
A - Award | 55 000 | 55 000 | |||||
| 2015-10-30 |
|
4 | CLVS |
Clovis Oncology, Inc.
Employee stock option (right to buy) |
M - Exercise | -4 000 | 23 034 | -14,80 | ||||
| 2015-10-30 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -238 | 0 | -100,00 | 99,22 | -23 614 | ||
| 2015-10-30 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -1 962 | 238 | -89,18 | 98,91 | -194 054 | 23 540 | |
| 2015-10-30 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -1 300 | 2 200 | -37,14 | 97,31 | -126 507 | 214 089 | |
| 2015-10-30 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -500 | 3 500 | -12,50 | 95,78 | -47 890 | 335 226 | |
| 2015-10-30 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 4 000 | 4 000 | 3,08 | 12 320 | 12 320 | ||
| 2015-10-07 |
|
4 | CLVS |
Clovis Oncology, Inc.
Employee stock option (right to buy) |
M - Exercise | -4 000 | 27 034 | -12,89 | ||||
| 2015-10-07 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -322 | 0 | -100,00 | 96,13 | -30 953 | ||
| 2015-10-07 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -400 | 322 | -55,40 | 93,92 | -37 570 | 30 244 | |
| 2015-10-07 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -2 221 | 722 | -75,47 | 93,01 | -206 566 | 67 150 | |
| 2015-10-07 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
S - Sale | -1 057 | 2 943 | -26,42 | 91,84 | -97 071 | 270 273 | |
| 2015-10-07 |
|
4 | CLVS |
Clovis Oncology, Inc.
Common Stock |
M - Exercise | 4 000 | 4 000 | 3,08 | 12 320 | 12 320 |